State NH
Clinical Trials in New Hampshire
New Hampshire is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Hampshire and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 44 actively recruiting studies with New Hampshire sites out of 44 registered in total. The busiest research areas in New Hampshire are Epilepsy, Breast Cancer, Metastatic Breast Cancer. Leading sponsors running trials in the state include Dartmouth-Hitchcock Medical Center, Yale University, National Cancer Institute (NCI). By stage, New Hampshire trials break down as Phase 1 (4), Phase 2 (9), Phase 3 (15).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Hampshire
Frequently Asked Questions — Clinical Trials in New Hampshire
How many clinical trials are currently recruiting in New Hampshire?
ClinicalMetric currently tracks 44 actively recruiting clinical trials with at least one location in New Hampshire. The total number of registered studies—including active but not currently enrolling trials—is 44. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Hampshire?
New Hampshire hosts clinical trials across a broad range of medical conditions, including Epilepsy, Breast Cancer, Metastatic Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Hampshire serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Hampshire?
To join a clinical trial in New Hampshire, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Hampshire maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Hampshire
NCT06422806 Phase 3
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone f...
Condition
Metastatic Dedifferentiated Liposarcoma
Enrollment
365 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07020819 Phase 3
Recruiting
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as AN...
Condition
Guillain-Barre Syndrome
Enrollment
30 pts
Location
United States, Denmark, France
Sponsor
Annexon, Inc.
NCT06456593 Phase 2
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active...
Condition
Moderately to Severely Active Crohn Disease
Enrollment
212 pts
Location
United States, Belgium, Czechia
Sponsor
Abivax S.A.
NCT07368647 N/A
Recruiting
Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Re...
Condition
Radiation Cystitis
Enrollment
100 pts
Location
United States
Sponsor
Rachel A. Moses
NCT06908538 N/A
Recruiting
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Li...
Condition
Amputation
Enrollment
2,000 pts
Location
United States
Sponsor
AtriCure, Inc.
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06810505 Phase 3
Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease...
Condition
Chronic Migraine
Enrollment
420 pts
Location
United States, Canada, Denmark
Sponsor
AbbVie
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
216 pts
Location
United States
Sponsor
Mayo Clinic
NCT06001736 N/A
Recruiting
Utility of CC7 Transfer in Stroke Subtypes
Condition
Stroke, Ischemic
Enrollment
95 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT06524544 Phase 3
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hzi...
Condition
Locally Advanced Urothelial Carcinoma
Enrollment
320 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT06111781 Phase 2
Recruiting
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Condition
Prostate Cancer
Enrollment
60 pts
Location
United States
Sponsor
Yale University
NCT06951919 N/A
Recruiting
HOBSCOTCH-MS-Efficacy Trial
Condition
Multiple Sclerosis
Enrollment
125 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
NCT04552275 Phase 1
Recruiting
The HALT Biomarker Study
Condition
Aortic Stenosis
Enrollment
300 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT04333537 Phase 2, Phase 3
Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...
Condition
Buccal Mucosa Squamous Cell Carcinoma
Enrollment
686 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT06937086 Phase 3
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants W...
Condition
Ulcerative Colitis
Enrollment
350 pts
Location
United States, Austria, Belgium
Sponsor
Eli Lilly and Company
NCT06381505 N/A
Recruiting
RetracTOR/ Retractor for Image Guided Trans-Oral Surgery
Condition
Oral Cavity Disease
Enrollment
20 pts
Location
United States
Sponsor
Ryan J. Halter
Page 2 of 2 — 44 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology